2012
DOI: 10.1111/j.1365-4632.2011.05245.x
|View full text |Cite
|
Sign up to set email alerts
|

The cutaneous manifestations of metastatic malignant melanoma

Abstract: Cutaneous metastases are common sequelae of primary malignant melanoma. Because patients with melanoma are examined frequently after diagnosis, it is important that dermatologists are aware of the range of findings that may represent metastatic disease. Many case reports and a few retrospective series have been published detailing the wide variety of clinical presentations of cutaneous metastatic melanoma. This article reviews the various manifestations of metastatic melanoma of the skin and oral mucous membra… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
21
0
1

Year Published

2013
2013
2020
2020

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 17 publications
(23 citation statements)
references
References 53 publications
1
21
0
1
Order By: Relevance
“…The skin is a frequent site of melanoma dissemination [3]. In approximately 30 % of cases cutaneous metastases are preceded by lymph node involvement [1]. As with other cutaneous tumor metastases, the spread of melanoma to the skin signifies a poor prognosis [3].…”
Section: Clinical Lettermentioning
confidence: 99%
See 3 more Smart Citations
“…The skin is a frequent site of melanoma dissemination [3]. In approximately 30 % of cases cutaneous metastases are preceded by lymph node involvement [1]. As with other cutaneous tumor metastases, the spread of melanoma to the skin signifies a poor prognosis [3].…”
Section: Clinical Lettermentioning
confidence: 99%
“…Melanoma is the most common metastatic tumor to the skin in men, and the second most common in women [1,2]. Cutaneous involvement by melanoma is detected in nearly 50 % of patients with disseminated disease [1].…”
mentioning
confidence: 99%
See 2 more Smart Citations
“…Diffuse melanosis cutis (DMC) is a rare presentation of metastatic melanoma characterized by a blue–gray discoloration of the skin and mucous membranes . We present the first reported case of DMC in which BRAF mutation testing has been performed and highlight the importance of mutation testing in the new era of targeted therapies for metastatic melanoma.…”
Section: Introductionmentioning
confidence: 98%